AzTrials
AzTrials

CircumcisionNCT04092998

Circumcision With Use of Thermocautery and Histopathological Changes

A study testing Thermocautery circumcision in people with Circumcision, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Histo pathological changes that occurs in thermo cautery circumcision and the range of damage prepuce from thermal effect in comparison with scalpel circumcision Read more about this study

Who is it for?
Ages 40 days and older, men onlyHealthy volunteers can take part
Conditions the study is for
Circumcision
What is being tested?
Thermocautery circumcision
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
1 Oct 2019to 20 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 days and older
  • Men only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • all male gender

Who cannot join

  • females
  • micro penis
  • hypospedias
  • epispedias
  • ambigilious genitalia

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Assiut university

    Asyut, 71511

    Recruiting

Other trials in Egypt

About this study

Official title: Histopathological Changes and Surgical Complications in Thermocautery Circumcision

Histo pathological changes that occurs in thermo cautery circumcision and the range of damage prepuce from thermal effect in comparison with scalpel circumcision

Read the detailed description

Circumcision is one of the most commonly performed surgical procedures worldwide. It is known that more than one million children are circumcised annually in the USA alone . Moreover, the WHO has begun to recommend circumcision on the basis of studies indicating its positive effects on human health and especially its role in protection from AIDS . Because of this, thousands of people have been circumcised by many migratory circumcision teams, especially in Africa.

Considering that 1 200 000 children are born annually in Turkey and 51% of them are male, on the basis of data from the Turkish Institute of Statistics, it may be speculated that about 60 000 circumcisions are performed annually in Turkey.

However, the circumcision procedure cannot be performed in health institutions as a routine procedure because of health regulations. When the Social Security Institute incorporated circumcision into the social insurance coverage in 2007, it led to circumcision being performed in the health institutions. Health institutions that were already burdened cannot meet the demands for circumcision. Thus, the search has begun for faster and reliable circumcision techniques with fewer complications. The present study aimed to compare bipolar thermal cautery-assisted circumcision technique, considered to be capable of meeting such demands, with the classical circumcision technique.

Aim of Work This study is aiming to assess the outcome of using thermo cautery in circumcision

Surgical Steps:

small skin incision over prepuce by thermo cautery

stitching if there is bleeding

Insertion of a urinary catheter if suspect uretheral injury

Conditions
Circumcision
Being tested
Thermocautery circumcision

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thermocautery circumcisionProcedure or surgery

    Also called scalpel circumcision

    Histopathological changes from thermocautery circumcision

Study groups in NCT04092998
Study groupRoleWhat they receive
Thermocautery VS scalpel circumcisionExperimentalThermocautery circumcision in comparison to circumcision with traditional scalpel
Receives: Procedure: Thermocautery circumcision

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. early wound complications

    wound infection (with or without removal of the mesh) wound necrosis wound hematoma bleeding

    Measured: 1 week

  2. late wound complications

    wound infection (with or without removal of the mesh) wound necrosis wound hematoma

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2019
  2. Study start1 Oct 2019 (estimated)
  3. Primary completion20 Oct 2020 (estimated)
  4. Study completion20 May 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
male infant presented for Circumcision
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04092998
Sponsor's protocol ID
Circumcision
Status last verified
Sep 2019
First submitted
16 Sep 2019
Last updated
20 Sep 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: age , sex , clinical diagnosis

Questions about this trial

What is this clinical trial studying?

A study testing Thermocautery circumcision in people with Circumcision, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact mohamed gamal (01007717127, mohamedgamalhassan0@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

early wound complications (time frame: 1 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in